In this context, pentamidine, an antiprotozoal agent, was identified to bind to the p53 binding site of S100B, thereby inhibiting S100B/p53 interaction, allowing p53 to restore tumour-suppressing properties [226,227]. This evidence concerns the gene S100B and neoplasm.